ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,459 | -13.0% | 70 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $1,677 | +27.3% | 70 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $1,317 | +18.2% | 70 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,114 | +11.4% | 70 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $1,000 | -50.0% | 70 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $2,000 | 0.0% | 70 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $2,000 | -50.0% | 70 | -68.2% | 0.00% | -50.0% |
Q3 2021 | $4,000 | -55.6% | 220 | -40.5% | 0.00% | -66.7% |
Q2 2021 | $9,000 | -10.0% | 370 | 0.0% | 0.01% | -14.3% |
Q1 2021 | $10,000 | -37.5% | 370 | +23.3% | 0.01% | -46.2% |
Q4 2020 | $16,000 | +33.3% | 300 | 0.0% | 0.01% | +8.3% |
Q3 2020 | $12,000 | – | 300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |